We propose that the two animal models of CNV (i.e., mouse and rabbit) with resistance to anti-VEGF therapies replicate the anti-VEGF resistance of human AMD and constitute valid models to test new therapies. The gene discussed is VEGFA; the disease is age-related macular degeneration.